Nasales Glukokortikoid Mometason aus der Verschreibungspflicht entlassen
Crossref DOI link: https://doi.org/10.1007/s15007-017-1311-2
Published Online: 2017-03-17
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,